ZUELLIG PHARMA INVESTS IN HEALTH BENEFIT CONSULTANTS

อังคาร 9 พฤษภาคม 2560 เวลา 14:46 น.

           Zuellig Pharma, the region's leading healthcare services provider, has today announced it has invested in Health Benefit Consultants Company (HBC) through its Malaysian subsidiary – MiCare Sdn Bhd.
          HBC is a leading third party administrator in Thailand providing medical claims administration and related consulting and advisory services to corporates and insurance companies. It was established in en993 and serves the needs of en7 Thai and three foreign companies.
          Zuellig Pharma Vice President Integrated Solutions Moses Hee said this partnership will focus on growing HBC in Thailand and expanding the services and health benefits it offers to Thai people.
          "We want to work closely with HBC to grow its existing business and help it better serve the needs of local Thai people, companies and insurers. The business is currently responsible for managing the health insurance of 2.5 million Thai people and we believe that there is a lot of potential for growth."
          HBC Managing Director Permsak Natenuj said the partnership will allow HBC to leverage Zuellig Pharma's regional networks and MiCare's technology and expertise.
          "Zuellig Pharma's strong regional networks and focus on developing innovative new solutions will help us to expand HBC's business and the services that we offer. This partnership will enable the development of technology and solutions that will deliver greater health benefits to the Thai people that we support."
          Zuellig Pharma's subsidiary, MiCare, is the leading partner for Payors in Malaysia, offering health and wellness as well as third party administration services to corporates and insurance companies. Zuellig Pharma will leverage MiCare's technology and expertise to bring new services to Thailand, in partnership with HBC.
          "MiCare offers corporates and insurance companies a range of services to improve the health of the people that they insure. This is not only good for the individual, it helps to reduce corporate healthcare and insurance costs," said Mr Hee.
          The solutions being piloted in Malaysia include mobile applications and health and wellness programmes.
          "These programmes are delivering strong results. A recent pilot that we ran with a local Malaysian corporate reduced the number of preventable new cases of chronic disease among its employees by 2Zuellig Pharma% and improved the health of more than 45% of the people that took part.
          "This resulted in a en4% reduction in the company's absentee rate and a en5% reduction in its employee medical expenses. We look forward to introducing similar programmes to the Thai market through our partnership with HBC," said Mr Hee.

ZUELLIG PHARMA INVESTS IN HEALTH BENEFIT CONSULTANTS

ข่าวZuellig Pharma+o:healวันนี้

CLINIXIR, A LEADING CONTRACT RESEARCH ORGANIZATION IN THAILAND, ANNOUNCES NEW CEO, DR. PUCHONG PADUNGSUTT

Dr. Puchong Padungsutt has assumed the role of CEO at Clinixir (www.clinixir.com ), Thailand's leading contract research organization (CRO). Dr. Padungsutt brings to Clinixir more than two decades of leadership in the medical and pharmaceutical industries. His career has spanned high-level positions, including Vice President of Medical Affairs and Country Medical Director at Zuellig Pharma, where he led cross-functional teams and launched products in therapeutic areas such as Oncology, Women's

17 ตุลาคม 2567 09:03 น.

Zuellig Pharma Receives EcoVadis Platinum Medal in 2021 For Sustainability — Zuellig Pharma, a leading healthcare services provider in Asia, has been awar... ต.ค. 64

Government Pharmaceutical Organization Confirms Purchase of Five Million Doses of COVID-19 Vaccine Moderna — The COVID-19 Vaccine Moderna will be availab... ก.ค. 64

International Finance Corporation จับมือ Mitsui เตรียมลงทุน 60 ล้านดอลลาร์สหรัฐใน MiCare Health Technologies ที่สิงคโปร์ — การลงทุนเชิงกลยุทธ์เพื่อช่วยขยา... พ.ค. 64

International Finance Corporation and Mitsui to invest c.US$60 million in Singapore-based MiCare Health Technologies — Strategic investment to help expand... พ.ค. 64

Zuellig Pharma Clinches Ecovadis Gold Medal 2021 For Sustainability — Zuellig Pharma, a leading healthcare services provider in Asia has been awarded the ... เม.ย. 64

Zuellig Pharma คว้าเหรียญทอง Ecovadis ปี 2021 ด้านความยั่งยืน — Zuellig Pharma ผู้ให้บริการเฮลธ์แคร์ระดับชั้นนำในเอเชีย ได้รับรางวัล Gold Medal 2021 จากผู... เม.ย. 64

Zuellig Pharma launches blockchain-based eZTracker in Thailand to help consumers verify authorized aesthetics products in seconds — Zuellig Pharma, a lead... ก.พ. 64

Zuellig Pharma expands cold storage warehouse capacity across key markets in Asia in preparation for COVID-19 vaccine — Zuellig Pharma, a leading healthca... พ.ย. 63

Zuellig Pharma แต่งตั้ง จอห์น เกรแฮม ดำรงตำแหน่งซีอีโอคนใหม่ — Zuellig Pharma ผู้ให้บริการดูแลสุขภาพชั้นนำในเอเชีย ประกาศแต่งตั้งคุณจอห์น เกรแฮม ดำรงตำแหน... ก.ค. 63